Ossiam Sells 1,193 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ossiam trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,328 shares of the medical equipment provider's stock after selling 1,193 shares during the quarter. Ossiam's holdings in Intuitive Surgical were worth $4,347,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after buying an additional 360,591 shares during the period. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. Finally, Invesco Ltd. increased its stake in Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of several recent research reports. Royal Bank of Canada decreased their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday. Piper Sandler lowered their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Stock Up 0.5 %

Shares of NASDAQ:ISRG traded up $2.69 during midday trading on Friday, reaching $510.82. 1,035,049 shares of the company traded hands, compared to its average volume of 1,609,274. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The firm's fifty day moving average price is $513.65 and its two-hundred day moving average price is $532.19. The firm has a market capitalization of $181.94 billion, a price-to-earnings ratio of 79.80, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the business earned $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.